Modulation of multidrug-resistant multiple myeloma by cyclosporin

This publication has 16 references indexed in Scilit:

• Multidrug-resistant myeloma: laboratory and clinical effects of verapamil as a chemosensitizer
  Blood, 1991
• Bepridil in combination with anthracyclines to reverse anthracycline resistance in cancer patients
  European Journal of Cancer and Clinical Oncology, 1991
• Expression of mdr1 and mdr3 Multidrug-resistance Genes in Human Acute and Chronic Leukemias and Association With Stimulation of Drug Accumulation by Cyclosporine
  JNCI Journal of the National Cancer Institute, 1990
• Overexpression of the MDRL gene in blast cells from patients with acute myelocytic leukemia is associated with decreased anthracycline accumulation that can be restored by cyclosporin‐A
  International Journal of Cancer, 1990
• P-glycoprotein expression in plasma-cell myeloma is associated with resistance to VAD
  Blood, 1989
• Immunohistochemical detection and quantitation of P-glycoprotein in multiple drug-resistant human myeloma cells: association with level of drug resistance and drug accumulation
  Blood, 1989
• A randomized trial of maintenance versus no maintenance melphalan and prednisone in responding multiple myeloma patients
  British Journal of Cancer, 1988
• Multiple-Drug Resistance in Human Cancer
  New England Journal of Medicine, 1987
• Expression of a full-length cDNA for the human "MDR1" gene confers resistance to colchicine, doxorubicin, and vinblastine.
  Proceedings of the National Academy of Sciences, 1987
• Ten-year survival in multiple myeloma
  Archives of internal medicine (1960), 1985